A machine learning derived echocardiographic algorithm identifies people at risk of heart failure with distinct cardiac structure, function, and response to spironolactone: the HOMAGE trial
20 May 2023 (08:00 - 20:00)
Organised by: 

About the speaker

Tokyo Medical University, Tokyo (Japan)
6 More presentations in this session
Miss A. Moya (Aalst, BE)
Access the full session
The Event
Heart Failure 2023
20 May - 23 May 2023
You may be interested in
Congress Presentation
Congress Presentation


